Abstract
Background
The purpose of this study was to evaluate the therapeutic effects of combination therapy with curcumin and alendronate on bone remodeling after ovariectomy in rats.
Methods
Eighty female Sprague-Dawley rats underwent either a sham operation (the sham group) or bilateral ovariectomy (OVX). The ovariectomized animals were randomly distributed amongst four groups: untreated OVX group, curcumin-administered group, alendronate-administered group, and the combination therapy group. At 8 and 12 weeks after surgery, rats from each of the groups were euthanized. Serum biochemical markers of bone turnover, including osteocalcin and alkaline phosphatase (ALP), and the telopeptide fragment of type I collagen C-terminus (CTX) were analyzed. Bone histomorphometric parameters of the 4th lumbar vertebrae were determined by micro-computed tomography (CT). In addition, mechanical strength was determined by a three-point bending test.
Results
Serum biochemical markers of bone turnover in the experiment groups (curcumin administered group, alendronate administered group, and the combination therapy group) were significantly lower than in the untreated OVX group (p < 0.05). The combination therapy group had lower ALP and CTX-1 concentrations at 12 weeks, which were statistically significant compared with the curcumin only and the alendronate only group (p < 0.05). The combination therapy group had a significant increase in BMD at 8 weeks and Cr.BMD at 12 weeks compared with the curcumin-only group (p = 0.005 and p = 0.013, respectively). The three point bending test showed that the 4th lumbar vertebrae of the combination therapy group had a significantly greater maximal load value compared to that of the curcumin only and the alendronate only group (p < 0.05).
Conclusions
The present study demonstrated that combination therapy with a high dose of curcumin and a standard dose of alendronate has therapeutic advantages over curcumin or alendronate monotherapy, in terms of the synergistic antiresorptive effect on bone remodeling, and improving bone mechanical strength.
Similar content being viewed by others
Abbreviations
- ALP:
-
Alkaline phosphatase
- BMD:
-
Bone mineral density
- BV/TV:
-
Trabecular bone volume fraction
- CTX:
-
C-terminal telopeptide fragment of type I collagen C-terminus
- micro-CT scan:
-
Micro-computed tomography scan
- OVX:
-
Ovariectomy
- Tb.Th.:
-
Trabecular thickness
- Tb.N.:
-
Trabecular number
- Tb.Sp.:
-
Trabecular separation
References
Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, Papadimitropoulos EA, Hopman W, Poliquin S, Prior JC, Hanley DA, Olszynski WP, Anastssiades T, Brown JP, Murray T, Jackson SA, Tenenhouse A, Canadian Multicentre Osteoporosis Study (CaMos) Research Group (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12(11):903–908
Bell NH (2003) RANK ligand and the regulation of skeletal remodeling. J Clin Invest 111(8):1120–1122
Bharti AC, Takada Y, Aggarwal BB (2004) Curcumin (diferuloylmethane) inhibits receptor activator of NF-kB ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172(10):5940–5947
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475
Canpolat S, Tug N, Seyran AD, Kumru S, Yilmaz B (2010) Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats. J Physiol Biochem 66(1):23–28
Fleisch H (1998) Bisphosphonate: mechanisms of action. Endocr Rev 19:80–100
French DL, Muir JM, Webber CE (2008) The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. Phytomedicine 15(12):1069–1078
Folwarczna J, Zych M, Trzeciak HI (2010) Effects of curcumin on the skeletal system in rats. Pharmacol Rep 62(5):900–909
Joe B, Vijaykumar M, Lokesh BR (2004) Biological properties of curcumin-celluar and molecular mechanisms of action. Crit Rev Food Sci Nutr 44(2):97–111
Kashii M, Hashimoto J, Nakano T, Umakoshi Y, Yoshikawa H (2008) Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats. J Bone Miner Metab 26(1):24–33
Notoya M, Nishimura H, Woo JT, Nagai K, Ishihara Y, Hagiwara H (2006) Curcumin inhibits the proliferation and mineralization of cultured osteoblasts. Eur J Pharmacol 534(1–3):55–62
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294–1301
Oh S, Kyung TW, Choi HS (2008) Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol Cells 26(5):486–489
Ott SM (2005) Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90(3):1897–1899
Ozaki K, Kawata Y, Amano S, Hanazawa S (2000) Stimulatory effect of curcumin on osteoclast apoptosis. Biochem Pharmacol 59(12):1577–1581
Park SB, Lee YJ, Chung CK (2010) Bone mineral density changes after ovariectomy in rats as an osteopenic model: stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc 48(4):309–312
Park SK, Oh S, Shin HK, Kim SH, Ham J, Song JS, Lee S (2011) Synthesis of substitute triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis. Bioorg Med Chem Lett 21(12):3573–3577
Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115(12):3318–3325
Sakai S, Endo K, Takeda S, Mihara M, Shiraishi A (2012) Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength. Bone 50(5):1054–1063
Salari P, Abdollahi M (2012) Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharm Sci 15(2):305–317
Shishodia S, Sethi G, Aggarwal BB (2005) Curcumin: getting back to the roots. Ann N Y Acad Sci 1056:206–217
Szulc P, Meunier PJ (2003) Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. Joint Bone Spine 70(3):157–160
Watts NB, Diab DL (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95(4):1555–1565
Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteoporosis. N Engl J Med 349:457–463
Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853:183–189
Yang MW, Wang TH, Yan PP, Chu LW, Yu J, Gao ZD, Li YZ, Guo BL (2011) Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine 18(2–3):205–213
Acknowledgment
This work was supported by Biomedical Reserach Institute grant, Kyungpook National University Hospital (2011).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, DC., Kim, KT., Jeon, Y. et al. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat. Acta Neurochir 154, 2215–2223 (2012). https://doi.org/10.1007/s00701-012-1516-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-012-1516-9